Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Growth Analysis | Trends, Drivers and Vendor Forecasts for 2021-2025

Technavio has been monitoring the enzyme-linked immunosorbent assay (Elisa) testing market and it is expected to grow by $ 265.55 mn, decelerating at a CAGR of almost 9% during the forecast period. The growth trajectory of the market is traced through a detailed analysis of the prevalent market forces, trends, and drivers along with competitive benchmarking

Enzyme-linked Immunosorbent Assay (Elisa) Testing Market: Receive Free Sample Report

Enzyme-linked Immunosorbent Assay (Elisa) Testing Market: Key Trends to impact market growth

North America has been recording a significant growth rate and is expected to offer several growth opportunities to market vendors during the forecast period. Rise in toxicology testing in food industry will facilitate the enzyme-linked immunosorbent assay (ELISA) testing market growth in North America. This research report provides a detailed impact analysis of all the trends that are likely to influence the growth of the market in focus.

Enzyme-linked Immunosorbent Assay (Elisa) Testing Market: Top Drivers to Boost Demand

Growing need for frequent diagnostic testing among aging population is one of the primary factors driving the growth of the enzyme-linked immunosorbent assay (Elisa) testing market. Growth by the hospitals and diagnostic centers segment has been significant in recent years and is expected to offer further growth opportunities during the forecast period. The report provides a detailed study of all the factors that are likely to boost the market. This analysis will enable clients to leverage growth opportunities to their advantage and set their business

Vendor Analysis: Abcam Plc, Agilent Technologies Inc. and Becton, Dickinson and Co. are key growth contributors

The market is fragmented. The research report provides insights into the top market player and their product portfolio along with a pipeline analysis of upcoming developments and growth opportunities. The growth of the players depends on several factors such as market conditions, government support, and industry development. To survive and succeed in such an intensely competitive market, players must distinguish their product and service offerings through clear and unique value propositions. Abcam Plc, Agilent Technologies Inc., Becton, Dickinson and Co., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, PerkinElmer Inc., QIAGEN NV, and Thermo Fisher Scientific Inc. are some of the major market participants.

For more insights on this market: Download a Free Sample Report

Enzyme-linked Immunosorbent Assay (Elisa) Testing Market: Key Highlights of the Report for 2021-2025

• CAGR of the market during the forecast period 2021-2025
• Detailed information on factors that will drive enzyme-linked immunosorbent assay (Elisa) testing market growth during the next five years
• Precise estimation of the enzyme-linked immunosorbent assay (Elisa) testing market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the enzyme-linked immunosorbent assay (Elisa) testing market industry across North America, Europe, Asia, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of enzyme-linked immunosorbent assay (Elisa) testing market vendors